Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Declaring Opioid Emergency, Trump Touts FDA Actions, NIH-Industry Partnerships

Oct 27 2017

• By Brenda Sandburg

Trump_Donald_160716_1200x675

Related Content

FDA's Opioid Programs: After Training, What's The Next Step?

Oct 05 2017

Addiction Recovery Medications' 'Stigma' Needs To Be Eliminated, Gottlieb Says

Oct 26 2017

Curtain Falls On Opana ER As Endo Agrees To US FDA Withdrawal Request

Jul 06 2017

Related Companies

Endo, Inc.

CVS Health Corp.

Additional Topics

United States Policy FDA BioPharmaceutical Neurology

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.